October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone software for ECG analysis. The Cardiomatics ECG interpretation platform is used by more than 200 clinics and 1,000 medical professionals.

October 12, 2023 — Royal Philips, a global leader in health technology, and the 

October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which houses a needle and ultrasound in one system for use in atrial transseptal procedures and delivery of catheters, has now been successfully used in 15 human cases, at major cardiology hospitals in Arizona and Minnesota. 

October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces completion of enrollment in its 

October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications almost a year later, a national study led by Nanyang Technological University, Singapore (NTU Singapore) and affiliated faculty has found. 

October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today released new data for TN-301 at the 2023 Heart Failure Society of America (HFSA) Annual Scientific Meeting.

October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE HealthCare and University Hospitals (UH) announced a 10-year strategic collaboration to bring GE HealthCare technologies to UH across its radiology practice and UH Harrington Heart & Vascular Institute, providing contemporary equipment and

October 11, 2023 — A newly-issued American Heart Association presidential advisory identifies the strong connections among cardiovascular disease (CVD), kidney disease, Type 2 diabetes and obesity, and suggests redefining CVD risk, prevention and management.


October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy, DAIC's Managing Editor conducted an in-depth interview with 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now